Milner – LifeArc strategic partnership extended for five years
We are thrilled to announce that the Milner collaboration with the medical research charity LifeArc has been expanded into a 5-year strategic partnership until 2026. The Milner Computational Research team, led by Namshik Han, have been collaborating closely with the...
Milner Institute wins award for innovation at Cambridge Independent Science and Technology Awards
We are honoured to have been announced as highly commended in the Innovation category of the 2022 Cambridge Independent Science & Technology Awards. Milner Director Kathryn Chapman was presented with the trophy at the awards ceremony held last night. Several...
Milner Therapeutics Institute promoted to Affiliated Institute of CRUK Cambridge Centre
We are delighted to announce that, with the renewal of the CRUK Cambridge Centre this year, the Milner will become an Affiliated Institute, reflecting our central role in supporting researchers across Cambridge. Over the past five years, the Onco-Innovation programme...
MTI welcomes George Freeman MP, to learn how Cambridge is leading innovation in life sciences
We were delighted to welcome George Freeman MP, the Parliamentary under Secretary of State in the Department for Business, Energy and Industrial Strategy, for a visit to the Milner Therapeutics Institute last week. Mr Freeman met with MTI Directors Tony Kouzarides and...
Director Tony Kouzarides receives Cyprus Excellence in Science award
The President of Cyprus, Nicos Anastasiades, presented our Director Tony Kouzarides with the prestigious Excellence in Science Award this week, on behalf of the Cyprus Academy of Science. The ceremony took place at the Presidential Palace in Cyprus, during...
Milner Institute wins OBN Award for Most Impactful Business Support Organisation
This week, Deputy Director Kathryn Chapman and Communications Manager Nikki Mann represented the Milner team at the OBN Awards in Oxford, and we are delighted to announce that the Milner Therapeutics Institute won in the category for Most Impactful Business Support...
KPBMA bring international partners to Milner affiliate network
We are delighted to share that KPBMA (Korea Pharmaceutical and Bio-Pharma Manufacturers Association) has joined as an Affiliated Organization of the Milner Therapeutics Institute today. KPBMA is the largest industry member organization in South Korea, which is based...
Astellas join Milner Therapeutics Consortium
We are delighted to announce that Astellas have joined the Milner Therapeutics Consortium as our 11th pharma partner. Astellas, a global pharmaceutical company headquartered in Japan, works across more than 70 countries in the US, Europe and Asia. They bring to the...